Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature

Abstract

Ischaemic stroke is one of the commonest causes of morbidity and mortality worldwide and around a fifth of events can be attributed to a cardioembolic source. This is typically due to atrial fibrillation (AF), the most common sustained cardiac arrhythmia. However, AF can, at times, be difficult to detect due to a relative lack of symptoms and the fact that it can be paroxysmal in nature. Studies have shown that diagnosis of AF improves as the length of cardiac monitoring increases. However, prolonged cardiac monitoring is not a cost-effective way of diagnosing AF. Therefore, an alternative approach may be to empirically anticoagulate individuals who are at high risk of stroke. This article summarises current evidence surrounding stroke risk prediction, the use of anticoagulation in the secondary prevention of stroke and its use in the primary prevention of stroke in high risk groups with the aim of determining whether empirical anticoagulation is a safe and effective strategy.

Prevalence and Detection Methods for Atrial Fibrillation in Patients Hospitalized due to Ischemic Stroke and Its Impact on Clinical Patient Outcomes

“…Components of thromboembolic risk are also risk factors for AF itself, and these results suggest the need for more frequent screening of AF in patients with a higher CHA 2 DS 2 -VASc score 27 .…”